The Board of Directors of the Company have approved the unaudited Financial Results for the Quarter ended June 30th 2025 at their meeting held on July 23, 2025.
Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2025.
Filed with BSE ·
On 6ix: 6ix.com/news/board-meeting-outcome-for-financial-results-for-the-quarter-ended-june-30-2025-1
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 16 2025
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2025
Later from Venmax Drugs & Pharmaceuticals
- Financial Results For The Quarter Ended June 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 23 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 24 2025
- Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals